5:23 PM
 | 
May 02, 2013
 |  BC Extra  |  Company News

Arena withdrawing Belviq MAA

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) disclosed in its 1Q13 financial results that it is withdrawing an MAA from EMA for Belviq lorcaserin to gain more feedback on the application for the obesity drug from EMA's CHMP. The MAA sought approval of the

Read the full 198 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >